Aurobindo Pharma informs about press release

19 Jul 2017 Evaluate

Aurobindo Pharma has informed about a press release titled ‘Aurobindo Pharma receives USFDA Approval for Sevelamer Carbonate tablets’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1114.90 5.10 (0.46%)
18-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1523.80
Dr. Reddys Lab 5959.10
Cipla 1352.95
Zydus Lifesciences 934.50
Lupin 1599.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.